Alex Aravanis, Illumina chief technology officer
Illumina and Deerfield link arms to drive 'genomics-first' drug discovery
After years of partnering with the pharma industry, Illumina is now making its own foray into drug discovery. The DNA sequencing company is entering a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.